Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis
Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis
Recruiting · NCT07477639 · Registry updated 2026-09-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis | CNS demyelinating autoimmune disease, Chronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, autoimmune disease, autoimmune disorder of the nervous system, chronic progressive multiple sclerosis, demyelinating disease, immune system disorder, multiple sclerosis, nervous system disorder | Recruiting | Phase 1 / Phase 2 | 2026-09-21 | NCT07477639 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Tr1X, Inc. | 3 |
8 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Duke University | Durham | United States | 160 |
| Mayo Clinic | Rochester | United States | 1 |
| Mt. Sinai | New York | United States | 7 |
| Providence Swedish | Seattle | United States | 1 |
| UC San Diego | La Jolla | United States | 9 |
| University of Cincinnati | Cincinnati | United States | 55 |
| University of Kansas Medical Center | Kansas City | United States | 240 |
| Washington University, St. Louis | St Louis | United States | 10 |